Delivery Order SPE2DB20D1109-SPE2DB25FP82Q
- Not listed
- The Defense Logistics Agency awarded a $4,176.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.15 mg epinephrine auto-injectors (two-pack units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,237.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.15 mg auto-injectors (2-pack) on August 15, 2025, with completion scheduled for August 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $10,998.99. This competitively awarded, firm fixed-price delivery order is set to conclude by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard medical supply procurement supporting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This $4,480.59 firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026. No set-aside...
- The Defense Logistics Agency awarded a $2,720.43 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs under a firm fixed-price contract. This non-set-aside award was issued on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,772.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injectors (2-pack) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $6,040.16 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on July 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $3,630.66 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector two-packs. This firm fixed-price contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP82QDelivery Order
The Defense Logistics Agency awarded a $6,238.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The delivery order was competitively awarded with no set-aside designation, and performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania by September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering diverse pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm's delivery orders typically employ firm fixed pricing structures and range substantially in value, reflecting its capability to fulfill both routine and specialized medical supply requirements through the DLA Medical Supply Chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/24/25 |